Regulation of MYCN expression in human neuroblastoma cells

BackgroundAmplification of the MYCN gene in neuroblastoma (NB) is associated with a poor prognosis. However, MYCN-amplification does not automatically result in higher expression of MYCN in children with NB. We hypothesized that the discrepancy between MYCN gene expression and prognosis in these children might be explained by the expression of either MYCN-opposite strand (MYCNOS) or the shortened MYCN-isoform (ΔMYCN) that was recently identified in fetal tissues. Both MYCNOS and ΔMYCN are potential inhibitors of MYCN either at the mRNA or at the protein level.MethodsExpression of MYCN, MYCNOS and ΔMYCN was measured in human NB tissues of different stages. Transcript levels were quantified using a real-time reverse transcriptase polymerase chain reaction assay (QPCR). In addition, relative expression of these three transcripts was compared to the number of MYCN copies, which was determined by genomic real-time PCR (gQPCR).ResultsBoth ΔMYCN and MYCNOS are expressed in all NBs examined. In NBs with MYCN-amplification, these transcripts are significantly higher expressed. The ratio of MYCN:ΔMYCN expression was identical in all tested NBs. This indicates that ΔMYCN and MYCN are co-regulated, which suggests that ΔMYCN is not a regulator of MYCN in NB. However, the ratio of MYCNOS:MYCN expression is directly correlated with NB disease stage (p = 0.007). In the more advanced NB stages and NBs with MYCN-amplification, relatively more MYCNOS is present as compared to MYCN. Expression of the antisense gene MYCNOS might be relevant to the progression of NB, potentially by directly inhibiting MYCN transcription by transcriptional interference at the DNA level.ConclusionThe MYCNOS:MYCN-ratio in NBs is significantly correlated with both MYCN-amplification and NB-stage. Our data indicate that in NB, MYCN expression levels might be influenced by MYCNOS but not by ΔMYCN.

[1]  P. F. Kauff.  Group , 2000, Elegant Design.

[2]  K. Matthay.  MYCN expression in neuroblastoma: A mixed message? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Frank Speleman,et al.  Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. , 2007, Methods in molecular biology.

[4]  D. Stram,et al.  International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors , 2001, Cancer.

[5]  F. Penault-Llorca,et al.  aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer , 2003, Breast Cancer Research.

[6]  Ben Lehner,et al.  In search of antisense. , 2004, Trends in biochemical sciences.

[7]  M Schwab,et al.  Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Cheung,et al.  The MYCN enigma: significance of MYCN expression in neuroblastoma. , 2006, Cancer research.

[9]  F. Speleman,et al.  Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay , 2002, Modern Pathology.

[10]  Michael Ashburner,et al.  Annotation of the Drosophila melanogaster euchromatic genome: a systematic review , 2002, Genome Biology.

[11]  Erez Y. Levanon,et al.  Widespread occurrence of antisense transcription in the human genome , 2003, Nature Biotechnology.

[12]  D. Stram,et al.  Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[14]  A. Casson,et al.  Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells. , 2005, Leukemia research.

[15]  P. Haber,et al.  Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Jay Shendure,et al.  Computational discovery of sense-antisense transcription in the human and mouse genomes , 2002, Genome Biology.

[17]  Ben Lehner,et al.  Antisense transcripts in the human genome. , 2002, Trends in genetics : TIG.

[18]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[19]  J. Lunec,et al.  Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? , 2003, Cancer letters.

[20]  M. Schwab,et al.  Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. , 1995, Cancer research.

[21]  H. Brunner,et al.  Genotype–phenotype correlations in MYCN‐related Feingold syndrome , 2008, Human mutation.

[22]  C. Thrash-Bingham,et al.  aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. , 1999, Journal of the National Cancer Institute.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  G. Krystal,et al.  Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[25]  M. Schwab.  MYCN in neuronal tumours. , 2004, Cancer letters.

[26]  Hans van Bokhoven,et al.  MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome , 2005, Nature Genetics.

[27]  Izabela Makalowska,et al.  Overlapping genes in vertebrate genomes , 2005, Comput. Biol. Chem..

[28]  K. Ihara,et al.  Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. , 2004, Journal of pediatric surgery.

[29]  L. Stanton,et al.  Alternative processing of RNA transcribed from NMYC , 1987, Molecular and cellular biology.

[30]  J. Battey,et al.  N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts , 1990, Molecular and cellular biology.

[31]  C. Vaché,et al.  Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. , 2002, Gene.